Market Tracker

11/20 12:26pm ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

2.91
Delayed Data
As of 12:10pm ET
 -0.07 / -2.35%
Today’s Change
1.83
Today|||52-Week Range
7.15
+50.00%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close2.98
Today’s open3.03
Day’s range2.87 - 3.03
Volume108,151
Average volume (3 months)168,215
Market cap$34.4M
Dividend yield--
Data as of 12:10pm ET, 11/20/2017

Growth & Valuation

Earnings growth (last year)+22.05%
Earnings growth (this year)+25.93%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)-19.90%
P/E ratioNM
Price/Sales0.11
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NTRPNeurotrope Inc0.000.00%
PPHMPPeregrine Pharmaceut...+0.02+0.08%
TCONTRACON Pharmaceutica...-0.15-5.45%
AMPEAmpio Pharmaceutical...-0.02-1.63%
Data as of 12:10pm ET, 11/20/2017

Financials

Next reporting dateMarch 28, 2018
EPS forecast (this quarter)-$3.90
Annual revenue (last year)$140.9M
Annual profit (last year)-$169.6M
Net profit margin-120.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
John A. Sedor
President, Chief Financial Officer &
Director
Graham G. Miao
Corporate headquarters
Morristown, New Jersey

Forecasts